SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Símbolo de cotizaciónSIBN
Nombre de la empresaSI-BONE Inc
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoMs. Laura A. Francis
Número de empleados349
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 17
Dirección471 El Camino Real, Suite 101
CiudadSANTA CLARA
Bolsa de valoresMoscow Interbank Currency Exchange (MICEX)
PaísUnited States of America
Código postal95050
Teléfono14082070700
Sitio Webhttps://si-bone.com/
Símbolo de cotizaciónSIBN
Fecha de salida a bolsaOct 17, 2018
Director ejecutivoMs. Laura A. Francis
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos